BVIC — Britvic Share Price
Last trade - 00:00- £3.01bn
- £3.79bn
- £1.75bn
- 92
- 30
- 100
- 89
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 15.44 | ||
| PEG Ratio (f) | 2.04 | ||
| EPS Growth (f) | 8.17% | ||
| Dividend Yield (f) | 3.22% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 8.49 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 18.78 | ||
| Price to Sales | 1.48 | ||
| EV to EBITDA | 13.11 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 16.48% | ||
| Return on Equity | 36.42% | ||
| Operating Margin | 10.57% | ||
Financial Summary
| Year End 30th Sep | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 1,545 | 1,412.4 | 1,405.1 | 1,618.3 | 1,748.6 | 1,898.88 | 1,972.27 | 3.07% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -3.51 | -15.26 | -18.36 | +24.62 | +16.04 | +3.75 | +9.76 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Britvic plc is a United Kingdom-based soft drinks company. The Company operates in the soft drinks manufacturing and distribution industry. Its range of drinks include Barley water, family favorites, fruit creations, others. It operates through five segments: GB, Brazil, Ireland, France and International. The GB segment include its operations in the United Kingdom excluding Northern Ireland. In Great Britain, its brands include Robinsons, J2O, Fruit Shoot, R Whites and Purdeys. The Ireland segment includes its operations in Republic of Ireland and Northern Ireland. In Ireland, its portfolio includes brands, such as Ballygowan, MiWadi, Club, TK and Cidona. In France, the Company operates private label syrups business, and its brands include Teisseire, Pressade and Moulin de Valdonne brands. In Brazil, it supplies liquid concentrates. Its brands in Brazil include Maguary, Bela Ischia and Dafruta. The International segment includes branded flavored concentrates.
Directors
- John Daly NEC
- Simon Litherland CEO (56)
- Joanne Wilson CFO
- Zareena Brown CHO
- Matt Barwell CMO
- Clare Thomas GCN
- Hessel De Jong MDR
- Joao de Mello Neto MDR
- Kevin Donnelly MDR
- Paul Graham MDR
- Pedro Magalhaes MDR
- Steve Potts MDR
- Sue Clark NID
- William Eccleshare NID
- Emer Finnan NID (52)
- Ian Mchoul NID (61)
- Euan Sutherland NID
- Last Annual
- September 30th, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- October 27th, 2005
- Public Since
- December 8th, 2005
- No. of Shareholders
- 2,502
- No. of Employees
- 4,537
- Sector
- Beverages
- Industry
- Consumer Defensives
- Exchange
- London Stock Exchange
- Shares in Issue
- 248,940,555
- Address
- Breakspear Park, Breakspear Way, HEMEL HEMPSTEAD, HP2 4TZ
- Web
- https://www.britvic.com/
- Phone
- +44 1217111102
- Contact
- Steve Nightingale
- Auditors
- Deloitte LLP
Latest News for BVIC
Upcoming Events for BVIC
Q3 2024 Britvic PLC Trading Statement Release
Full Year 2024 Britvic PLC Earnings Release
Similar to BVIC
A G Barr
London Stock Exchange
C&C
London Stock Exchange
Chapel Down
London Stock Exchange
Coca-Cola Europacific Partners
London Stock Exchange
Coca Cola HBC AG
London Stock Exchange
FAQ
As of Today at 19:43 UTC, shares in Britvic are trading at 1,094.00p. This share price information is delayed by 15 minutes.
Shares in Britvic last closed at 1,094.00p and the price had moved by +25.24% over the past 365 days. In terms of relative price strength the Britvic share price has outperformed the FTSE All Share Index by +13.05% over the past year.
The overall consensus recommendation for Britvic is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Britvic dividend yield is 2.93% based on the trailing twelve month period.
Last year, Britvic paid a total dividend of £0.32, and it currently has a trailing dividend yield of 2.93%.Looking ahead, the next dividend pay date is 2024-07-05.
We do not have data on when Britvic is to next pay dividends. The historic dividend yield on Britvic shares is currently 2.93%.
To buy shares in Britvic you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 1,094.00p, shares in Britvic had a market capitalisation of £2.72bn.
Here are the trading details for Britvic:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: BVIC
Based on an overall assessment of its quality, value and momentum Britvic is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Britvic is 1,053.57p. That is 3.7% below the last closing price of 1,094.00p.
Analysts covering Britvic currently have a consensus Earnings Per Share (EPS) forecast of £0.66 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Britvic. Over the past six months, its share price has outperformed the FTSE All Share Index by +22.5%.
As of the last closing price of 1,094.00p, shares in Britvic were trading +25.7% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Britvic PE ratio based on its reported earnings over the past 12 months is 15.44. The shares last closed at 1,094.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Britvic's management team is headed by:
- John Daly - NEC
- Simon Litherland - CEO
- Joanne Wilson - CFO
- Zareena Brown - CHO
- Matt Barwell - CMO
- Clare Thomas - GCN
- Hessel De Jong - MDR
- Joao de Mello Neto - MDR
- Kevin Donnelly - MDR
- Paul Graham - MDR
- Pedro Magalhaes - MDR
- Steve Potts - MDR
- Sue Clark - NID
- William Eccleshare - NID
- Emer Finnan - NID
- Ian Mchoul - NID
- Euan Sutherland - NID